Literature DB >> 3323590

Stewart-Treves syndrome. A report of two cases with a review of Japanese literature.

M Noguchi1, H Hasegawa, K Tajiri, X De Aretxabala, I Miyazaki, S Terahata, K Tomita.   

Abstract

Two cases of postmastectomy lymphangiosarcoma seen at our department are reported. One case, treated by amputation, died 1 year 4 months later and the other case, treated by local excision followed by amputation, died 7 months later. Twenty cases from the Japanese literature, including our 2 cases, are reviewed herein. The initial treatment for the other 18 cases was as follows: amputation in 8 cases, local excision in 2, radiotherapy in 4 and chemotherapy in 4. Fifteen of 16 cases eligible for follow up were dead within 20 months after treatment. Although the knowledge available as to the results of the treatment of postmastectomy lymphangiosarcoma is still insufficient to indicate the optimal therapeutic approach, early recognition of the lesion and prompt radical ablative surgery seem to offer the best chance for survival.

Entities:  

Mesh:

Year:  1987        PMID: 3323590     DOI: 10.1007/BF02470642

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  11 in total

1.  Lymphangio-sarcoma arising in chronic lymphedematous extremities. Report of thirteen cases and review of literature.

Authors:  H F TASWELL; E H SOULE; M B COVENTRY
Journal:  J Bone Joint Surg Am       Date:  1962-03       Impact factor: 5.284

2.  Angiosarcoma in post-mastectomy lymphoedema; a report of 5 cases and a review of the literature.

Authors:  E M McCONNELL; P HASLAM
Journal:  Br J Surg       Date:  1959-01       Impact factor: 6.939

3.  Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica.

Authors:  F W STEWART; N TREVES
Journal:  Cancer       Date:  1948-05       Impact factor: 6.860

4.  Lymphangiosarcoma arising in chronic lymphedematous extremities.

Authors:  A H Woodward; J C Ivins; E H Soule
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

Review 5.  Lymphangiosarcoma of the chronically edematous extremity.

Authors:  J B Herrmann
Journal:  Surg Gynecol Obstet       Date:  1965-11

6.  [Case of postmastectomy lymphangiosarcoma].

Authors:  N Sakaguchi; K Kuno
Journal:  Gan No Rinsho       Date:  1970-02

7.  Chemotherapy for postmastectomy lymphangiosarcoma.

Authors:  B S Yap; H Y Yap; C M McBride; G P Bodey
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

8.  Postmastectomy lymphangiosarcoma: a reappraisal of the concept--a critical review and report of an illustrative case.

Authors:  K Schafler; C G McKenzie; R Salm
Journal:  Histopathology       Date:  1979-03       Impact factor: 5.087

9.  Stewart-Treves syndrome. A lethal complication of postmastectomy lymphedema and regional immune deficiency.

Authors:  H Schreiber; F M Barry; W C Russell; W L Macon; J L Ponsky; W J Pories
Journal:  Arch Surg       Date:  1979-01

10.  Lymphangiosarcoma.

Authors:  P P Sordillo; R Chapman; S I Hajdu; G B Magill; R B Golbey
Journal:  Cancer       Date:  1981-10-01       Impact factor: 6.860

View more
  4 in total

1.  Stewart Treves Syndrome: A Case Report.

Authors:  Ali Güleç; Harun Kütahya; Nazım Karalezli; Burkay Kacira; M Ali Acar
Journal:  Oman Med J       Date:  2014-03

Review 2.  Angiosarcoma (Stewart-Treves syndrome) in postmastectomy patients: report of 10 cases and review of literature.

Authors:  Lifang Cui; Jixin Zhang; Xinmin Zhang; Hong Chang; Congling Qu; Jiangying Zhang; Dingrong Zhong
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Stewart Treves Syndrome in a Woman with Mastectomy.

Authors:  Sevil Alan; Habibullah Aktas; Ömer Faik Ersoy; Alpay Aktümen; Harun Erol
Journal:  J Clin Diagn Res       Date:  2016-02-01

4.  Stewart-Treves Syndrome Involving Chronic Lymphedema after Mastectomy of Breast Cancer.

Authors:  Smain Nabil Mesli; Amin Khayreddine Ghouali; Fouad Benamara; Fouzi Ahmed Taleb; Hicham Tahraoui; Chakib Abi-Ayad
Journal:  Case Rep Surg       Date:  2017-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.